Blenrep

GSK Advances Blenrep’s Potential Comeback with Second Phase III Win
BioSpace
Thu, 03/7/24 - 05:32 pm
GSK
Blenrep
antibody-drug conjugate
clinial trials
GSK reports positive news on trio of high-profile products
Medical Marketing and Media
Wed, 02/7/24 - 09:13 pm
GSK
Arexvy
RSV
Abrysvo
Blenrep
GSK’s Blenrep Combo Scores Phase III Win in Multiple Myeloma
BioSpace
Tue, 02/6/24 - 09:25 am
GSK
Blenrep
Multiple Myeloma
clinical trials
GSK cancer drug Blenrep gets surprise trial win
BioPharma Dive
Tue, 11/28/23 - 10:19 am
GSK
Blenrep
clinical trials
Multiple Myeloma
JPM23: Is GSK's 15-day accelerated approval withdrawal the new normal? Hear FDA Commissioner Robert Califf's response
Fierce Pharma
Thu, 01/12/23 - 09:20 pm
JPMHC 2023
GSK
Blenrep
clinical trial
FDA
Robert Califf
GSK’s “crown jewels” already look tarnished
EP Vantage
Wed, 11/23/22 - 07:27 am
GSK
Blenrep
Emma Walmsley
daprodustat
gepotidacin
otilimab
Jemperli
Zejula
cabotegravir
GSK to pull blood cancer drug from US market after study failure
BioPharma Dive
Tue, 11/22/22 - 11:08 am
GSK
blood cancer
Blenrep
clinical trials
Multiple Myeloma
Time for GSK to stop dreaming about Blenrep
EP Vantage
Mon, 11/7/22 - 10:53 am
GSK
BCMA
Blenrep
clinical trials
Multiple Myeloma
GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep
Fierce Biotech
Mon, 08/8/22 - 11:45 pm
GSK
Mersana
antibody-drug conjugate
Blenrep
XMT-2056